Does PEGVISOMANT Cause Product dose omission issue? 255 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 255 reports of Product dose omission issue have been filed in association with PEGVISOMANT (SOMAVERT). This represents 8.5% of all adverse event reports for PEGVISOMANT.
255
Reports of Product dose omission issue with PEGVISOMANT
8.5%
of all PEGVISOMANT reports
2
Deaths
36
Hospitalizations
How Dangerous Is Product dose omission issue From PEGVISOMANT?
Of the 255 reports, 2 (0.8%) resulted in death, 36 (14.1%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGVISOMANT. However, 255 reports have been filed with the FAERS database.
What Other Side Effects Does PEGVISOMANT Cause?
Off label use (460)
Drug ineffective (328)
Insulin-like growth factor increased (320)
Headache (244)
Fatigue (224)
Arthralgia (184)
Death (162)
Injection site pain (161)
Product use issue (158)
Diarrhoea (151)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which PEGVISOMANT Alternatives Have Lower Product dose omission issue Risk?
PEGVISOMANT vs PEGZEREPOETIN ALFA
PEGVISOMANT vs PEMBROLIZUMAB
PEGVISOMANT vs PEMETREXED
PEGVISOMANT vs PEMIGATINIB
PEGVISOMANT vs PENICILLAMINE